Agreement Between Varian and Embolx Paves the Way for Advanced Image-Guided Therapies for Cancer
PALO ALTO, Calif.–(BUSINESS WIRE)–Varian, a Siemens Healthineers company, announced a U.S. co-marketing and sales agreement with Embolx for the sale and market development of the Sniper Balloon Occlusion Microcatheter. This announcement marks a leap forward for liver-directed therapies by enabling a full range of embolization and ablation solutions from a single vendor, providing options for advanced image-guided therapies along the cancer patient’s journey.
The Sniper Balloon Occlusion Microcatheter is an innovative tool that expands on traditional embolization use cases by utilizing a pressure-directed balloon system for occlusion in the peripheral vasculature. By altering blood flow-dynamics and controlling local blood pressure, clinicians are afforded precise coverage for the delivery of embolic agents into target areas, effectively starving a tumor of blood supply while protecting surrounding healthy tissues.
